MHA Specialty Clinical Services Leader Stacey Ness Named As Next President of IgNS

October 25, 2017

October 25, 2017 (Florham Park, NJ): Managed Health Care Associates, Inc. (MHA), a leading health care services and technology company focused on the alternate site health care provider marketplace, is pleased to share that Immunoglobulin National Society (IgNS) has named Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, Senior Director of MHA Specialty Clinical Services, as the next President. Dr. Ness will serve a two-year term effective January 1, 2018.

Ig National Society is a professional organization dedicated to the advancement and sustaining of Ig therapy practice across clinical indications and areas of practice. Luba Sobolevsky, PharmD, the founding executive director of IgNS, stated, “We are very pleased to have Stacey assume the role of President. Her experience and insight into the clinical practice as well as the industry will provide us with a unique blend of strength in strategy, advancement of education, member engagement, and innovative industry collaborations.”

Dr. Ness serves as the Senior Director of Specialty Clinical Services at MHA, and in that capacity has presented studies at the three most recent annual IgNS conferences on the positive impact to adherence and infection rates in patients being managed by pharmacies utilizing the immune globulin therapy module of MHA’s Specialty Pharmacy Solutions proprietary Clinical Therapy Management™ patient management software application, as well as the business growth that those pharmacies have experienced. MHA has established a leading presence offering infusion and specialty pharmacies and pharmaceutical business partners a strong contract portfolio, innovative patient management solutions and key metrics capture. The studies presented by Dr. Ness exemplify that leadership by way of documented positive results for patients and pharmacies alike.

“IgNS is regarded as the central organization in the Ig therapy field and is unique in its ability to bring together stakeholders,” said Dr. Ness. “I look forward to extending the IgNS platforms and addressing the needs of healthcare professionals, patients, and our industry. It’s a great honor to serve as the next IgNS President.”

Kimberly Binaso-Stwalley, PharmD, RPh, BS, BCGP, FASCP, FASHP, VP of Clinical Services at MHA, commented, “MHA is committed to attract the best and brightest, and we’re excited and proud to see a key professional organization look to our people for leadership. Both the IgNS organization and Stacey’s role in leading it are consistent with MHA’s mission to deliver excellent value and enable the success of our Members, and lead the industry.” 

About MHA
Managed Health Care Associates, Inc. (MHA) is a leading health care services and software company that offers a growing portfolio of services and solutions to support the diverse and complex needs of the alternate site health care provider. MHA provides expertise in Group Purchasing, Managed Care and Payor Contracting, Reimbursement Management, Specialty Pharmacy Solutions, Pharmaceutical Data Analytics, Consultant Pharmacy Software and Legislative Advocacy. Through the delivery of innovative health care services and solutions, MHA helps Members increase operational efficiency, maximize business growth and provide optimum care for their patients. For more information, visit

For More Information Contact:
Elisabeth Overend
VP of Marketing
Managed Health Care Associates, Inc.
800-642-3020 X9374